Differential activation of dual signaling responses by human H1 and H2 histamine receptors

Journal of Receptors and Signal Transduction

Volumn 23, Issue 1, 2003, Pages 17-31

  Esbenshade, Timothy A ^a   Kang, Chae Hee ^a   Krueger, Kathleen M ^a   Miller, Thomas R ^a   Witte, David G ^a   Roch, Jean M ^b   Masters, Jeffrey N ^c   Hancock, Arthur A ^a  

^a ABBOTT LABORATORIES   (United States)

^b Myriad Genetic Laboratories   (United States)

^c PFIZER INC   (United States)

Author keywords

Constitutive activity; Cyclic AMP; FLIPR; GPCR; Histamine; Intracellular calcium

Indexed keywords

CALCIUM ION; CIMETIDINE; COMPLEMENTARY DNA; CYCLIC AMP; DIMAPRIT; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE AGONIST; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; ISOBUTYLMETHYLXANTHINE; RANITIDINE;

ARTICLE; BINDING AFFINITY; DRUG POTENCY; DRUG RECEPTOR BINDING; EMBRYO; FLUORESCENCE; FLUORESCENCE IMAGING PLATE READER; HUMAN; HUMAN CELL; KIDNEY CELL; MONOLAYER CULTURE; NEUROTRANSMITTER RELEASE; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION;

CALCIUM SIGNALING; CELL LINE; CYCLIC AMP; DIMAPRIT; FORSKOLIN; HISTAMINE; HISTAMINE AGONISTS; HUMANS; KINETICS; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0037237156     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1081/RRS-120018758     Document Type: Article

References (33)

1. Hough L. Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 2001; 59(3):415-419.
2. Leurs R, Smit M, Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 1995; 66(3):413-463.
3. Hill S, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. International union of pharmacology. XIII. classification of histamine receptors. Pharmacol Rev 1997; 49(3):253-278.
4. DelValle J, Gantz I. Novel insights into histamine H2 receptor biology. Am J Physiol 1997; 273(5):G987-G996.
5. Leurs R, Hoffmann M, Wieland K, Timmerman H. H3 receptor gene is cloned at last. Trends Pharmacol Sci 2000; 21(1):11-12.
6. Fukui HFK, Mizuguchi H, Sakamoto K, Horio Y, Takai S, Yamada K, Ito S. Molecular cloning of the human histamine H1 receptor gene. Biochem Biophys Res Commun 1994; 201(2):894-901.
7. Gantz I, Schaffer M, DelValle J, Logsdon C, Campbell V, Uhler M, Yamada T. Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci USA 1991; 88(2):429-433.
8. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG. Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 1999; 55(6):1101-1107.
9. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000; 275(47):36781-36786.
10. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000; 279(2):615-620.
11. Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF. Discovery of a novel member of the histamine receptor family. Mol Pharmacol 2001; 59(3):427-433.
12. Liu CL, Ma XJ, Jiang XX, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li XB, Chai WY, Carruthers N, Lovenberg TW. Cloning and pharmacological characterization of a fourth histamine receptor (H-4) expressed in bone marrow. Mol Pharmacol 2001; 59(3):420-426.
13. Smit MJ, Timmerman H, Alewijnse AE, Leurs R. From histamine H2 receptor regulation to reclassification of H2 antagonists; inverse agonism as the basis for H2 receptor upregulation. Receptors Channels 1998; 5:99-102.
14. Alewijnse AE, Smit MJ, Hoffmann M, Verzijl D, Timmerman H, Leurs R. Constitutive activity and structural instability of the wild-type human H2 receptor. J Neurochem 1998; 71(2):799-807.
15. Alewijnse AE, Smit MJ, Rodriguez Pena MS, Verzijl D, Timmerman H, Leurs R. Modulation of forskolin-mediated adenylyl cyclase activation by constitutively active G(S)-coupled receptors. FEBS Lett 1997; 419(2-3):171-174.
16. Smit MJ, Leurs R, Alewijnse AE, Blauw J, Van Nieuw Amerongen GP, Van De Vrede Y, Roovers E, Timmerman H. Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc Natl Acad Sci USA 1996; 93(13):6802-6807.
17. Wang L, Gantz I, DelValle J. Histamine H2 receptor activates adenylate cyclase and PLC via separate GTP-dependent pathways. Am J Physiol 1996; 271:G613-G620.
18. DelValle J, Wang L, Gantz I, Yamada T. Characterization of H2 histamine receptor: linkage to both adenylate cyclase and [Ca2+]i signaling systems. Am J Physiol 1992; 263(6):G967-972.
19. Seifert R, Hoer A, Schwaner I, Buschauer A. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominately via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation. Mol Pharmacol 1992; 42(2):235-241.
20. Mitsuhashi M, Mitsuhashi T, Payan DG. Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. J Biol Chem 1989; 264(31):18356-18362.
21. Miller TR, Witte DG, Ireland LM, Kang CH, Roch JM, Masters JN, Esbenshade TA, Hancock AA. Analysis of apparent noncompetitive responses to competitive H1-histamine receptor antagonists in fluorescent imaging plate reader-based calcium assays. J Biomol Screen 1999; 4:249-258.
22. Stanimirovic DB, Bertrand N, Merkel N, Bembry J, Spatz M. Interaction between histamine and adenosine in human cerebromicrovascular endothelial cells: modulation of second messengers. Metab Brain Dis 1994; 9(3):275-289.
23. Fitzsimons C, Molinari B, Duran H, Palmieri M, Davio C, Cricco G, Bergoc R, Rivera E. Atypical association of H1 and H2 histamine receptors with signal transduction pathways during multistage mouse skin carcinogenesis. Inflamm Res 1997; 46(8):292-298.
24. Gantz I, Munzert G, Tashiro T, Schaffer M, Wang L, DelValle J, Yamada T. Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 1991; 178(3):1386-1392.
25. Esbenshade TA, Hancock AA. Characterization of histaminergic receptors. Curr Prot Pharmacol 2000; 1:1.19.1-1.19.19.
26. 50) of an enzymatic reaction. Biochem Pharmacol 1973; 22:2099-2108.
27. Hancock AA, Vodenlich AD, Maldonado C, Janis R. Alpha2-adrenergic agonist-induced inhibition of cyclic AMP formation in transfected cell lines using a microtiter-based scintillation proximity assay. J Recept Signal Transduct Res 1995; 15(1-4):557-579.
28. Kenakin T. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci 1997; 18(12):456-464.
29. Kenakin T. Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J 2001; 15(3):598-611.
30. Houston C, Wenzel-Seifert K, Burckstummer T, Seifert R. The human histamine H2 receptor couples more efficiently to Sf9 insect cell Gs proteins than to insect cell Gq proteins: limitations of Sf9 cells for analysis of receptor/Gq protein coupling. J Neurochem 2002; 80(4):678-696.
31. Wang LD, Hoetzel M, Gantz I, Hunter R, DelValle J. Characterization of the histamine H2 receptor structural components involved in dual signaling. J Pharmacol Exp Therap 1998; 285(2):573-578.
32. Gespach C, Saal F, Cost H, Abita JP. Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Mol Pharmacol 1982; 22:547-553.
33. Hoffman M, Verzijl D, Lundstrom K, Simmen U, Alewijnse AE, Timmerman H, Leurs R. Recombinant Semliki Forest virus for over-expression and pharmacological characterization of the histamine H2 receptor in mammalian cells. Eur J Pharmacol 2001; 427:105-114.